Consensus equity research estimates and mid-term technical price models tracking RPG Life Sciences project a 12-month average target price clustering around ₹2,750, with optimistic bull-case expectations scaling up to ₹3,350. These projections factor in anticipated revenue scaling from its API expansion strategies and continued volume growth across its domestic branded formulation lines.